EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Novel therapeutic approaches to target neurodegeneration

Alerie G de la Fuente iD, Silvia Pelucchi iD, Jerome Mertens iD, Monica Di Luca iD, Daniela Mauceri iD, Elena Marcello iD

British Journal of Pharmacology · 2023-07 · 180 (13) · 1651-1673

DOI: 10.1111/bph.16078 ↗

At a glance

Übersichtsarbeit in British Journal of Pharmacology, published online on 2023-04-26. Written by Alerie G de la Fuente and 5 co-authors. Institution: Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain. Major MEDLINE topics: Protein Aggregates, Neurodegenerative Diseases. Cited 31 times so far (Crossref); 214 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIA NIH HHS, Wellcome Trust, Ministero dell'Università e della Ricerca.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Ageing is the main risk factor common to most primary neurodegenerative disorders. Indeed, age‐related brain alterations have been long considered to predispose to neurodegeneration. Although protein misfolding and the accumulation of toxic protein aggregates have been considered as causative events in neurodegeneration, several other biological pathways affected by brain ageing also contribute to pathogenesis. Here, we discuss the evidence showing the involvement of the mechanisms controlling neuronal structure, gene expression, autophagy, cell metabolism and neuroinflammation in the onset and progression of neurodegenerative disorders. Furthermore, we review the therapeutic strategies currently under development or as future approaches designed to normalize these pathways, which may then increase brain resilience to cope with toxic protein species. In addition to therapies targeting the insoluble protein aggregates specifically associated with each neurodegenerative disorder, these novel pharmacological approaches may be part of combined therapies designed to rescue brain function.

Subjects

MeSH terms (MEDLINE)

Protein AggregatesNeurodegenerative DiseasesHumansProteinsAutophagy

Author keywords

autophagydendritegene expressionmetabolismneurodegenerative disordersneuroinflammationsynapse

Substances

Protein AggregatesProteins

Authors and institutions

  • Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
  • Instituto de Neurociencias CSIC-UMH, Alicante, Spain.
  • Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.
  • Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
  • Institute of Molecular Biology, Leopold-Franzens-Universität Innsbruck, Innsbruck, Austria.
  • Department of Neurosciences, University of California San Diego, La Jolla, California, USA.

ORCID profiles: Alerie G de la Fuente, Silvia Pelucchi, Jerome Mertens, Monica Di Luca, Daniela Mauceri, Elena Marcello

Funding

  • NIA NIH HHS
  • Wellcome Trust
  • Ministero dell'Università e della Ricerca
  • Fondazione Cariplo
  • Alzheimer Forschung Initiative
  • Chica and Heinz Schaller Foundation
  • Instituto de Salud Carlos III
  • BrightFocus Foundation

Cite

APA

de la Fuente, A. G., Pelucchi, S., Mertens, J., Di Luca, M., Mauceri, D., & Marcello, E. (2023). Novel therapeutic approaches to target neurodegeneration. British Journal of Pharmacology, 180(13), 1651-1673. https://doi.org/10.1111/bph.16078

Vancouver

de la Fuente AG, Pelucchi S, Mertens J, Di Luca M, Mauceri D, Marcello E. Novel therapeutic approaches to target neurodegeneration. British Journal of Pharmacology. 2023;180(13):1651-1673. doi:10.1111/bph.16078

BibTeX
@article{delaFuente2023,
  author = {de la Fuente, Alerie G and Pelucchi, Silvia and Mertens, Jerome and Di Luca, Monica and Mauceri, Daniela and Marcello, Elena},
  title = {Novel therapeutic approaches to target neurodegeneration},
  journal = {British Journal of Pharmacology},
  year = {2023},
  volume = {180},
  number = {13},
  pages = {1651--1673},
  doi = {10.1111/bph.16078}
}
Start for free →